Consumer-only investor that leads Series A, runs small funds, uses an 18-month pre-round relationship-building process, and is dedicated to personalized consumer experiences in health, productivity and knowledge. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing nascent-stage companies tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX. With a disciplined investment approach, the team drives value for both founders and investors.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Crypto-native operators who architect token-first ecosystems via token design, governance, and collective bootstrapping, empowering founders construct enduring token economies from day one and backing 100+ on-chain projects.
Is dedicated to impactful businesses aiming to positively transform the world's food system.
Longstanding crypto established record and relationships, plus a pioneering tokenized. A key differentiator: tradable LP structure that pays on-chain dividends via security tokens.
Seed and formative-stage lead/co-lead investor backing veteran teams in education, safety & care, and environment/climate, delivering Goldman-level analytical rigor and explicit, quantified impact theses. With a disciplined investment approach, the team drives value for both founders and investors.
